Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Almstedt, K.; Mendoza, S.; Battista, M. J. et al.
EndoPredict (R) in early hormone receptor-positive, HER2-negative breast cancer: Impact on clinical decisions and clinico-pathological factors influencing its applicationGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 80. H. 10. 2020 S. E93-E93
Almstedt, K.; Mendoza, S.; Otto, M. et al.
EndoPredict(R) in early hormone receptor-positive, HER2-negative breast cancerBREAST CANCER RESEARCH AND TREATMENT. Bd. 182. H. 1. 2020 S. 137-146
Smyth, Elizabeth Catherine; Knoedler, Maren Kristina; Nilsson, Magnus et al.
EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients with resected gastric cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): An open-label randomized controlled phase II studyJOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Mazzei-Abba, Antonella; Folly, Christophe L.; Coste, Astrid et al.
Epidemiological studies of natural sources of radiation and childhood cancer: current challenges and future perspectivesJOURNAL OF RADIOLOGICAL PROTECTION. Bd. 40. H. 1. 2020
Mayer, Anna; Tsiouris, Angeliki; Wiltink, Joerg et al.
EPOS: Development and Evaluation of an Emotion-Based Psychosocial Online Self-Help Program for Cancer PatientsONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 151-151
Bogucka, Katarzyna; Pompaiah, Malvika; Marini, Federico et al.
ERK3/MAPK6 controls IL-8 production and chemotaxisELIFE. Bd. 9. 2020
Schmidt, Marcus; Hoenig, Arnd; Zimmerman, Yvette et al.
Estetrol for treatment of advanced ER+/HER2-breast cancerCANCER RESEARCH. Bd. 80. H. 4. 2020
Heinicke, Thomas; Labopin, Myriam; Polge, Emmanuelle et al.
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMTLEUKEMIA & LYMPHOMA. 2020
Bostel, T.; Dreher, C.; Wollschlaeger, D. et al.
Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2-and diffusion-weighted MRIRADIATION ONCOLOGY. Bd. 15. H. 1. 2020
Ray-Coquard, Isabelle; Cibula, David; Mirza, Mansoor R. et al.
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancerINTERNATIONAL JOURNAL OF CANCER. Bd. 146. H. 2. 2020 S. 439-448